Shenzhen, China

Xiaoling Liang


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
3 patents (USPTO):

Title: Inventor Spotlight: Xiaoling Liang from Shenzhen, CN

Introduction

Xiaoling Liang is an innovative inventor based in Shenzhen, China, known for his groundbreaking work in cancer treatment. With a focus on tumor antigen-specific T cells, Liang has contributed significantly to the field of immunotherapy, earning him recognition and respect among his peers. As of now, he holds three patents that showcase his expertise and dedication to advancing cancer treatment methodologies.

Latest Patents

Among Xiaoling Liang's latest patents are methods of cancer treatment utilizing tumor antigen-specific T cells. This patent outlines innovative procedures for preparing these specialized cells. The method involves enriching activated T cells from a first co-culture comprising antigen-loaded dendritic cells and T cells, followed by co-culturing enriched activated T cells with a second population of antigen-loaded dendritic cells. Furthermore, this patent also describes methods of treating cancer in individuals with the use of these tumor-specific T cells, including the development of pharmaceutical compositions and kits for cell-based cancer immunotherapy.

Another key patent by Liang details methods for obtaining tumor-specific T cell receptors (TCRs). This innovation provides a way to extract a variety of TCRs that can specifically recognize target tumor antigen peptides from individuals who have benefitted from immunotherapy, such as Multiple Antigen Specific Cell Therapy. The patent also describes the engineering of immune cells that express these specific TCRs as a potential avenue for treating various diseases.

Career Highlights

Xiaoling Liang's career has been marked by significant contributions to the field of biotechnology. He has held prominent positions in well-respected companies like Syz Cell Therapy Co. and Hryz (Shenzhen) Biotech Co., where he collaborated with teams to advance cancer research and treatment approaches. His commitment to innovation has helped propel his career and the advancements of the organizations he has been part of.

Collaborations

Throughout his career, Xiaoling Liang has worked alongside esteemed colleagues, including Xiangjun Zhou and Yanyan Han, who have also been instrumental in the development of their projects. These collaborations have enriched his knowledge and skills in the field and fostered a dynamic environment for creativity and scientific exploration.

Conclusion

Xiaoling Liang stands out as a prominent figure in the realm of cancer research and immunotherapy. His patents reflect a forward-thinking approach that could significantly impact cancer treatment strategies. With his expertise and collaborative spirit, Liang continues to contribute to the evolution of biotechnology, making strides toward improving patient outcomes in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…